3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myelomonocytic, Acute
4
Leukemia, Myeloid, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Erythroblastic, Acute
4
Lymphoma, Non-Hodgkin
3
Wilms Tumor
2
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Melanoma
2
Medulloblastoma
2
Leukemia, Myelomonocytic, Chronic
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Ependymoma
2
Congenital Abnormalities
2
Breast Neoplasms
2
Brain Neoplasms
2
Anemia, Refractory, with Excess of Blasts
2
Xanthogranuloma, Juvenile
1
Interventions
Tretinoin
5
Methotrexate
5
Tacrolimus
4
Arsenic Trioxide
4
fludarabine phosphate
3
Peripheral Blood Stem Cell Transplantation
3
Busulfan
3
Mycophenolic Acid
2
Mercaptopurine
2
Idarubicin
2
Gemtuzumab
2
Filgrastim
2
Cytarabine
2
Cyclophosphamide
2
Antilymphocyte Serum
2
thymoglobulin
1
entinostat
1
Whole-Body Irradiation
1
Vorinostat
1
Sorafenib
1
Sirolimus
1
Granulocyte Colony-Stimulating Factor
1
Erlotinib Hydrochloride
1
Daunorubicin
1
Clofarabine
1
Bortezomib
1
Biopsy
1
Azacitidine
1
Alemtuzumab
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Promyelocytic, Acute
×
tipifarnib
×
Clear all
No trials found.